Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1291PDF: 1036HTML: 235 -
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4872PDF: 1831HTML: 2730Untitled: 235 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
868PDF: 490HTML: 1310 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1717PDF: 832HTML: 940cover letter: 284 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1414PDF: 869HTML: 146 -
-
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2202PDF: 1144HTML: 7718cover letter paper final AML: 232 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
4017PDF: 765HTML: 1858 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3286PDF: 916HTML: 1549Fig.1 CHL-R paper: 228Fig 2 CHL-R paper: 252 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1377PDF: 1267HTML: 465 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7742PDF: 2455HTML: 1745Table 1.: 227Table 2.: 239Table 3.: 222Table 4.: 216 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4112PDF: 1169HTML: 2004Fig.1: 223Fig. 2: 114Table 1: 210Table2: 228Table 3: 206 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1149PDF: 554HTML: 1702Figures: 179Fifures Sanz: 187tables Sanz: 188Untitled: 185 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1624PDF: 644HTML: 550 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1357PDF: 588Suppl. Files: 360HTML: 163 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1814PDF: 588HTML: 304 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1859PDF: 1014HTML: 148 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1664PDF: 811HTML: 871jdoe, table 2 infections CML .doc: 204jdoe, table 1 infections CML .doc: 195 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2016PDF: 915HTML: 704 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2683PDF: 763HTML: 2319 -
-
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4418PDF: 1784HTML: 1112 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3628PDF: 2552HTML: 1525 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1061PDF: 561HTML: 7821







